C JUN, C FOS AND NEURONAL PROGRAMMED CELL DEATH
C JUN、C FOS 和神经元程序性细胞死亡
基本信息
- 批准号:2431282
- 负责人:
- 金额:$ 10.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-08-01 至 2000-05-31
- 项目状态:已结题
- 来源:
- 关键词:antisense nucleic acid apoptosis binding proteins cAMP response element binding protein complementary DNA embryo /fetus tissue /cell culture gene induction /repression genetic promoter element immunofluorescence technique laboratory rat neurogenetics neuropharmacology neurotrophic factors oligonucleotides oncoproteins oxidative stress peptidylprolyl isomerase phosphoproteins polymerase chain reaction protooncogene sympathetic nervous system transfection /expression vector western blottings
项目摘要
Programmed cell death (PCD) is a well-recognized developmental phenomenon
that occurs by a process of apoptosis. Recent evidence strongly suggests
that PCD also contributes to pathological conditions. Several lines of
evidence have indicated that PCD results from the expression of a specific
genetic program leading to proteins that kill the cell. We have identified
several genes whose expression in increased in sympathetic neurons
undergoing PCD in response to deprivation of the neurotrophic factor, NGF,
and many genes whose expression is decreased. We have presented evidence
that c-Jun, a transcription factor encoded by the one of the induced genes,
is required for neuronal PCD. We have also presented evidence that
implicate the Fos family as being necessary for apoptosis; in NGF-deprived
neurons, certain Fos family members, i.e., c-fos and fos B, are induced,
while other, potentially inhibitory family members, i.e., fra-1 and fra-2,
are repressed. These results led us to theorize that neuronal PCD depends
upon both the activation of certain genes, i.e., c-jun, and the repression
of other genes, i.e., fra-1 and fra-2. Since (i) the induction f c-jun is
the earliest detectable genetic event, (ii) c-Jun interacts with each Fos
family member, and (iii) c-Jun has been implicated specifically as
necessary for death, our current working hypothesis is that events that
induce c-jun, modulate the activity of c-Jun, and that emanate from the
actions of c-Jun, constitute critical portions of a biochemical and genetic
cascade that results in neuronal death. We propose a focused attack aimed
at evaluating this hypothesis.
We shall further define the roles of the jun and Fos family members in
neuronal death by using several molecular genetic approaches. We shall
analyze athe expression of these genes at athe protein level to investigate
possible post-transcriptional regulation. We shall examine the
protein:protein interactions among the Jun and Fos family members to
identify directly athe proteins that interact with c-Jun. We shall
evaluate whether agents that protect neurons from NGF deprivation, i.e.,
cAMP analogs and potassium depolarization, do so by activating CREB-2, a
transcription factor that these agents activate and that modulates c-Jun.
We shall determine the biochemical changes during apoptosis that depend on
c-Jun, to identify 'downstream" mechanisms of c-Jun action. We shall
identify the molecular and cellular mechanisms leading to the activation of
c-jun; this investigation will lead "upstream" in the temporal cascade of
events by evaluating the roles of oxidative stress and c-Jun
phosphorylation.
These studies will provide considerable insight into the role of the Jun
and Fos family members in neuronal PCD and athe overall mechanism of
neuronal PCD. Given the increasing evidence for a role of neuronal PCD in
pathological conditions of the nervous system, i.e., stroke, neurotoxicity,
and neurodegenerative disease, these insights may lead to strategies to
intervene pharmacologically to prevent or retard death in these conditions.
细胞程序性死亡是一种公认的发育现象
这是通过细胞凋亡过程发生的。 最近的证据有力地表明
PCD也会导致病理状况。 几行
有证据表明,PCD是由一种特定的
基因程序导致蛋白质杀死细胞。 我们已经确定
在交感神经元中表达增加的几个基因
经历PCD以响应神经营养因子NGF的剥夺,
以及许多表达减少的基因。 我们提供了证据
c-Jun,一种由诱导基因编码的转录因子,
是神经元PCD所必需的。 我们还提供了证据表明
暗示Fos家族是细胞凋亡所必需的;在缺乏NGF的
神经元,某些Fos家族成员,即,c-fos和fos B被诱导,
而其他的潜在抑制性家族成员,即,FRA-1和FRA-2,
被压抑了 这些结果使我们推测神经元PCD依赖于
在某些基因,即,c-jun和镇压
其他基因,即,FRA-1和FRA-2。 因为(i)归纳f c-jun是
最早可检测的遗传事件,(ii)c-Jun与每个Fos相互作用
家庭成员,以及(iii)c-Jun被特别牵连,
我们目前的工作假设是,
诱导c-jun,调节c-Jun的活性,
c-Jun的作用,构成了生物化学和遗传学的关键部分。
导致神经元死亡的级联反应。 我们建议集中攻击
评估这个假设。
我们将进一步明确jun和Fos家族成员的角色,
神经元死亡的分子遗传学方法。 我们将
分析这些基因在mRNA蛋白水平上的表达,
可能的转录后调节。 我们将研究
蛋白质:Jun和Fos家族成员之间的蛋白质相互作用,
直接鉴定与c-Jun相互作用的c-Jun蛋白。我们将
评估是否有保护神经元免受NGF剥夺的药物,即,
cAMP类似物和钾去极化,通过激活CREB-2,
这些试剂激活并调节c-Jun的转录因子。
我们将确定细胞凋亡过程中的生化变化,
c-Jun,确定c-Jun作用的“下游”机制。 我们将
确定导致激活的分子和细胞机制,
c-jun;这项调查将导致“上游”的时间级联
通过评估氧化应激和c-Jun的作用,
磷酸化
这些研究将提供相当深入的了解,
和Fos家族成员在神经元PCD中的作用及其整体机制
神经元PCD 鉴于越来越多的证据表明神经元PCD在
神经系统的病理状况,即,中风,神经毒性,
和神经退行性疾病,这些见解可能会导致策略,
在这些情况下进行干预,以防止或延缓死亡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Estus其他文献
Steven Estus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Estus', 18)}}的其他基金
How does D2-CD33 reduce Alzheimer's disease risk?
D2-CD33 如何降低阿尔茨海默病风险?
- 批准号:
10038417 - 财政年份:2020
- 资助金额:
$ 10.17万 - 项目类别:
The surprising impact of APOE alleles on gut microbiome: does altering the microbiome reduce AD risk?
APOE 等位基因对肠道微生物组的惊人影响:改变微生物组是否可以降低 AD 风险?
- 批准号:
9783096 - 财政年份:2018
- 资助金额:
$ 10.17万 - 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
- 批准号:
8696452 - 财政年份:2014
- 资助金额:
$ 10.17万 - 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
- 批准号:
9251728 - 财政年份:2014
- 资助金额:
$ 10.17万 - 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
- 批准号:
9038210 - 财政年份:2014
- 资助金额:
$ 10.17万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 10.17万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 10.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 10.17万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 10.17万 - 项目类别:
Discovery Grants Program - Individual